U.S Class(es): 100, 101
| Name | Novartis Pharma AG, |
|---|---|
| Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Feb-23-2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB | REPRM | |
| Feb-24-2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Mar-01-2016 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
| Apr-05-2016 | ASSIGNED TO EXAMINER | DOCKD | |
| Apr-12-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Apr-27-2016 | NOTICE OF PUBLICATION | NPUBO | |
| May-17-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Aug-02-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Sep-01-2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
| Sep-02-2016 | FINAL DISPOSITION PROCESSED | FIMPP | |
| Sep-02-2016 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
| Sep-23-2016 | NOTIFICATION PROCESSED BY IB | GPNXP | |
| Feb-17-2023 | CANCELLED SECTION 71 | C71TO | |
| Oct-17-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
| Oct-24-2023 | INVALIDATION PROCESSED | INPCP | |
| Oct-24-2023 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | INTSP | |
| Nov-12-2023 | TOTAL INVALIDATION PROCESSED BY THE IB | INNTP |